Medtronic, Inc. Announces First U.S. Clinical Trial Data on Transcatheter Valve for Congenital Heart Disease

NEW ORLEANS--(BUSINESS WIRE)--Today at the annual scientific sessions of the American Heart Association, the first U.S. clinical trial data on the Melody transcatheter pulmonary valve were presented. These findings also represent the first U.S. data on transcatheter valves in a population with congenital heart disease and the first reported U.S. data on the use of a transcatheter valve in the pulmonary position. The Melody valve is currently investigational in the U.S.